CONSENT OF RICHARD A EISNER & COMPANY LLP
Published on April 22, 1999
EXHIBIT 23.3
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to inclusion in this Post-Effective Amendment No. 5
to the Registration Statement on Form SB-2 of our report dated February 6, 1999
on our audits of the financial statements of Cytoclonal Pharmaceutics Inc., a
Delaware corporation, as of December 31, 1998 and 1997 and for each of the years
in the three-year period ended December 31, 1998. We also consent to the
reference of our firm under the captions "Experts" and "Selected Financial Data"
in the Prospectus.
/s/ Richard A. Eisner & Company, LLP
- --------------------------------------
Richard A. Eisner & Company, LLP
New York, New York
April 21, 1999